These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7733770)

  • 21. ['In vitro' activity of different antimicrobial agents on Gram-negative nonfermentative bacilli, excluding Pseudomonas aeruginosa and Acinetobacter spp].
    Vay CA; Almuzara MN; Rodríguez CH; Pugliese ML; Lorenzo Barba F; Mattera JC; Famiglietti AM
    Rev Argent Microbiol; 2005; 37(1):34-45. PubMed ID: 15991478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro activity of beta-lactam drugs and sulbactam against Chlamydia trachomatis.
    Segreti J; Kapell KS; Trenholme GM
    Diagn Microbiol Infect Dis; 1992; 15(4):371-3. PubMed ID: 1611854
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [In vitro antibacterial activity of cefoperazone-sulbactam].
    Zhang Y; Zhang J; Zhou L
    Zhonghua Nei Ke Za Zhi; 1995 Oct; 34(10):676-9. PubMed ID: 8731829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extended spectrum beta-lactamases among gram-negative bacteria from an Egyptian pediatric hospital: a two-year experience.
    Zaki Mel S
    J Infect Dev Ctries; 2007 Dec; 1(3):269-74. PubMed ID: 19734604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antimicrobial resistance of gram-negative isolates from intensive care units in Turkey: comparison to previous three years.
    Yücesoy M; Yuluğ N; Kocagöz S; Unal S; Cetin S; Calangu S
    J Chemother; 2000 Aug; 12(4):294-8. PubMed ID: 10949978
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The susceptibility of non-fermentative Gram-negative bacilli to cefperazone and sulbactam compared with other antibacterial agents.
    Fu W; Demei Z; Shi W; Fupin H; Yingyuan Z
    Int J Antimicrob Agents; 2003 Oct; 22(4):444-8. PubMed ID: 14522108
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro activities of piperacillin or cefoperazone alone and in combination with beta-lactamase inhibitors against gram-negative bacilli.
    Kuo HY; Wang FD; Yen YF; Lin ML; Liu CY
    New Microbiol; 2009 Jan; 32(1):49-55. PubMed ID: 19382669
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antimicrobial resistance of 100 serial gram-negative isolates in two intensive care units.
    Leelarasamee A; Janyapoon K
    J Med Assoc Thai; 1992 Dec; 75(12):680-7. PubMed ID: 1308536
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Sensitivity of multiresistant bacterial strains to imipenem (Tienam)].
    Ruczkowska J; Dolna I
    Przegl Lek; 1992; 49(5):151-3. PubMed ID: 1438917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro activity of minocycline alone and in combination with cefoperazone-sulbactam against carbapenem-resistant Acinetobacter baumannii.
    Pei G; Mao Y; Sun Y
    Microb Drug Resist; 2012 Dec; 18(6):574-7. PubMed ID: 22928863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multicentre study on antibiotic susceptibilities of anaerobic bacteria to cefoperazone-sulbactam and other antimicrobial agents.
    Clark RB; Bartelt MA; Chan EL; Dalton HP
    J Antimicrob Chemother; 1992 Jan; 29(1):57-67. PubMed ID: 1737725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibiotic susceptibility profiles of 941 gram-negative bacteria isolated from septicemic patients throughout Canada. The Canadian Study Group.
    Chamberland S; L'Ecuyer J; Lessard C; Bernier M; Provencher P; Bergeron MG
    Clin Infect Dis; 1992 Oct; 15(4):615-28. PubMed ID: 1420674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro comparison of cefoperazone/sulbactam with selected antimicrobials against 300 bacteroides isolates. Inhibitory activity and time-kill kinetic studies.
    Gelfand MS; Grogan JT; Haas MJ
    Diagn Microbiol Infect Dis; 1989; 12(5):421-8. PubMed ID: 2612130
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [In vitro comparison of ciprofloxacin with other antibiotics against multiresistant gram-negative bacilli].
    Soto Hernández JL; Angeles Morales V; Perea Mejía B; Hernández Velázquez M; Martínez Zubieta R; Pasquel Rivera C
    Rev Invest Clin; 1991; 43(4):318-22. PubMed ID: 1798865
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Urinary infection. I. Comparative in vitro activities of several antibiotic drugs against Gram-negative bacteria].
    Giachino F; Allocco A; Tuninetti L; Tullio V; Cuffini AM; Carlone NA
    G Batteriol Virol Immunol; 1992 Jan-1993 Dec; 85(1-12):55-67. PubMed ID: 7498617
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surveillance of antimicrobial resistance in gram-negative isolates from intensive care units in Turkey: analysis of data from the last 5 years.
    Leblebicioglu H; Gunaydin M; Esen S; Tuncer I; Findik D; Ural O; Saltoslu N; Yaman A; Tasova Y;
    J Chemother; 2002 Apr; 14(2):140-6. PubMed ID: 12017368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sulbactam-containing beta-lactamase inhibitor combinations.
    Akova M
    Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():185-8. PubMed ID: 18154545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In-vitro activity of cefoperazone-sulbactam combination against cefoperazone resistant clinical isolates in a Malaysian general hospital.
    Lim VK; Cheong YM
    Malays J Pathol; 1995 Dec; 17(2):73-6. PubMed ID: 8935129
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro activities of ampicillin-sulbactam and cefoperazone-sulbactam against oxacillin-susceptible and oxacillin-resistant staphylococci.
    Barry AL; Jones RN
    Antimicrob Agents Chemother; 1990 Sep; 34(9):1830-2. PubMed ID: 2285302
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro activity of imipenem and six other beta-lactam antibiotics against aminoglycoside resistant gram-negative bacilli.
    Bujdáková H; Kallová J; Lausová A; Kettner M
    Microbios; 1995; 84(339):87-90. PubMed ID: 8628124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.